Results 221 to 230 of about 106,571 (324)

Development and characterization of a nanoemulsion containing propranolol for topical delivery

open access: green, 2018
Zanela da Silva Marques T   +9 more
openalex   +1 more source

Effects of Propranolol and Exercise Training in Children with Severe Burns

open access: green, 2012
Laura J. Porro   +5 more
openalex   +2 more sources

Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale

open access: yesGeriatrics &Gerontology International, Volume 26, Issue 1, January 2026.
ABSTRACT The increased anticholinergic burden caused by medications in older adults is one of the adverse drug reactions of particular concern, as it can exacerbate the onset of geriatric syndromes or induce cognitive dysfunction, and is also related to the issue of polypharmacy.
Masaki Mogi   +4 more
wiley   +1 more source

Structural and Pharmacological Insights into Propranolol: An Integrated Crystallographic Perspective. [PDF]

open access: yesInt J Mol Sci
Witczyńska A   +4 more
europepmc   +1 more source

Persistent postural‐perceptual dizziness versus vestibular migraine: A narrative review

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 298-306, January 2026.
Abstract Objective This article reviews the differences and similarities between persistent postural‐perceptual dizziness (PPPD) and vestibular migraine. Background PPPD is considered a chronic functional vestibular disorder characterized by persistent dizziness, unsteadiness, nonspinning vertigo, and often exacerbated by upright posture, movement, or ...
David Moreno‐Ajona
wiley   +1 more source

Serum lipids and anticonvulsants [PDF]

open access: yes, 1982
Berlit, Peter   +3 more
core  

A retrospective audit of the real‐world safety and effectiveness profile of eptinezumab for treatment‐resistant chronic migraine in Australia

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 108-117, January 2026.
Abstract Objective To describe the real‐world safety, tolerability, and effectiveness of eptinezumab for chronic migraine prevention in Australia. Background Eptinezumab is a relatively new medication for treatment‐resistant chronic migraine prevention.
Lakshini Gunasekera   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy